Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 7—July 2026
Research
National Surveillance of Enterovirus D68 Upsurge, France, 2024
, and Enterovirus Surveillance Network1
Table 1
Patient characteristics and clinical outcomes in study of EV-D68 upsurge, France, 2024*
| Characteristic | Children 0–17 y, n = 363 | Adults |
||
|---|---|---|---|---|
| 18–64 y, n = 155 | >65 y, n = 134 | Total, n = 289 | ||
| Median age, y (IQR) | 2.0 (0.04–7) | 45 (34–56) | 76 (70–82) | 62 (43–75) |
| Female/male ratio | 0.76 | 0.49 | 0.55 | 1.08 |
| EV-D68 severe infections | 102/363 (28.1) | 38/155 (24.5) | 29/134 (21.6) | 67/289 (23.2) |
| Hospitalization† | 308/358 (86.0) | 126/150 (84.0) | 127/131 (96.9) | 253/281 (90.04) |
| Intensive care unit‡ | 85/343 (24.78) | 42/143 (29.4) | 27/125 (21.6) | 69/268 (25.75) |
| Death | 2/363 (0.6)§ | 3/155 (1.9) | 6/134 (4.5) | 9/289 (3.1)¶ |
*Values are no. (%) except as indicated. EV-D68, enterovirus D68; IQR, interquartile range. †Hospitalization requirement was reported for 358 children and 281 adults. ‡Intensive care requirement was reported for 343 children and 268 adults. §Sudden infant death syndrome. Although EV-D68 was the only detected pathogen, EV-D68 infection was considered as the possible cause of death; attributing causality can be challenging without thorough investigation in such contexts. ¶Among the 9 adults, the EV-D68 infection was considered as the probable cause of death in 4 patients (EV-D68 was the only detected pathogen) and as possible in 5 patients (evidence or strong suspicion of bacterial co-infection).
1Additional members of Enterovirus Surveillance Network who contributed data are listed at the end of this article.